Johnson & Johnson
Qing-qing Hu currently serves as a Senior Manager at 强生公司 since April 2021, focusing on the development and leadership of projects related to solid tumors, including colorectal, esophageal, and lung cancers, to meet regulatory and clinical requirements. Prior experience includes a role as a PhD Research Assistant at the University of Utah's Huntsman Cancer Institute from June 2017 to December 2020, concentrating on cancer epidemiology. Qing-qing Hu also worked in the local health promotion department at the Cixi Center for Disease Control and Prevention from July 2012 to June 2017, engaging in health promotion activities and data analysis. Additional experience includes serving as a Project Officer at the Chinese Centers for Disease Control and Prevention in 2010, and as a Research Assistant at the University of Utah from 2008 to 2010, where responsibilities included grant writing and program implementation. Qing-qing Hu holds a Master's degree in Health Promotion and Education from the University of Utah and a Bachelor of Medicine, Bachelor of Surgery (M.B.B.S.) in Preventive Medicine from Central South University.
This person is not in the org chart
This person is not in any offices
Johnson & Johnson
533 followers
Johnson & Johnson and its subsidiaries have approximately 141,700 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the healthcare field. Johnson & Johnson is a holding company, with operating companies conducting business in virtually all countries of the world. The Company’s primary focus is products related to human health and well-being. Johnson & Johnson was incorporated in the State of New Jersey in 1887. Johnson & Johnson is organized into three business segments: Consumer Health, Pharmaceutical and Medical Devices. The Consumer Health segment includes a broad range of products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women’s Health and Wound Care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology (e.g., rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease and psoriasis), Infectious Diseases (e.g., HIV/AIDS and COVID-19), Neuroscience (e.g., mood disorders, neurodegenerative disorders and schizophrenia), Oncology (e.g., prostate cancer, hematologic malignancies, lung cancer and bladder cancer), Cardiovascular and Metabolism (e.g., thrombosis, diabetes and macular degeneration) and Pulmonary Hypertension (e.g., Pulmonary Arterial Hypertension). Medicines in this segment are distributed directly to retailers, wholesalers, distributors, hospitals and healthcare professionals for prescription use. The Medical Devices segment includes a broad range of products used in the Interventional Solutions, Orthopaedics, Surgery, and Vision fields. At Johnson & Johnson, employees are guided by Our Credo which sets forth the Company’s responsibilities to patients, consumers, customers, healthcare professionals, employees, communities and shareholders. The Company is committed to workplace diversity and to cultivating, fostering, and advancing a culture of equity and inclusion. Enabling employees to perform at their best while being themselves is fundamental to the Company’s continued success. The Company’s DEI vision is: Be yourself, change the world.